Research sheds light on why some rheumatoid arthritis patients respond poorly to biologics

Distinct gene expression signatures in rheumatoid arthritis patients could help rheumatologists predict how these individuals will respond to tumor necrosis factor inhibitors, and may one day enable a more personalized approach …